- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,744.00
7D
3.6%
1Y
-15.8%
Sumitomo Pharma
Market Cap: JP¥642.6b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,405.50
7D
-9.7%
1Y
38.7%
GNI Group
Market Cap: JP¥170.3b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,612.00
7D
-8.6%
1Y
-16.3%
PeptiDream
Market Cap: JP¥131.4b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,018.00
7D
-1.0%
1Y
-38.8%
Nxera Pharma
Market Cap: JP¥83.4b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥920.00
7D
-5.2%
1Y
4.3%
SanBio
Market Cap: JP¥77.8b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥986.00
7D
-8.1%
1Y
-54.5%
Fuji Pharma
Market Cap: JP¥48.6b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,890.00
7D
-5.5%
1Y
42.4%
Heartseed
Market Cap: JP¥36.7b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,617.00
7D
-1.5%
1Y
-53.5%
Healios K.K
Market Cap: JP¥34.6b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥263.00
7D
5.2%
1Y
-49.1%
StemRIM
Market Cap: JP¥19.4b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥314.00
7D
0.3%
1Y
3.0%
Kidswell Bio
Market Cap: JP¥7.1b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥149.00
7D
-4.5%
1Y
-40.6%
Noile-Immune Biotech
Market Cap: JP¥5.6b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥135.00
7D
5.5%
1Y
-23.3%
TMS
Market Cap: JP¥4.6b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥103.00
7D
-4.6%
1Y
-41.8%